INTELLECTUAL PROPERTY PROTECTION AND DRUG PATENTS IN BRAZIL

Fuente: Redalyc
Guardado en:
Detalles Bibliográficos
Autor principal: Fabio Tozi
Formato: Artículo científico
Lenguaje:en
Publicado: Universidade Federal do Ceará 2020
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1876462397828366336
author Fabio Tozi
author_facet Fabio Tozi
contents INTELLECTUAL PROPERTY PROTECTION AND DRUG PATENTS IN BRAZIL Fabio Tozi Ciencias de la Tierra 19 COVID Patents Medicines Intellectual Property (IP) The article aims to reconstitute the central events of the Intellectual Property (IP) protection system in Brazil, highlighting the exception of medicines patent granting. In a second moment, we discuss the influences of corporations and of Special 301 Reports in the Intellectual Property Law (1996), which marks the recognition of drug patents granting in the country. Subsequently, we present an analysis of the growth of patents inthe largest offices, highlighting Brazil's peripheral participation in innovation. Finally, the article seeks to demonstrate the current relationship between patents and public health by considering the patent invalidation in Brazil and the international cooperation between States and corporations in developing vaccines during the COVID-19 pandemic. 2020 artículo científico 1984-2201 https://www.redalyc.org/articulo.oa?id=273664287004 https://www.redalyc.org/journal/2736/273664287004/ https://www.redalyc.org/journal/2736/273664287004/html/ https://www.redalyc.org/journal/2736/273664287004/273664287004.epub https://www.redalyc.org/journal/2736/273664287004/movil https://doi.org/10.4215/rm2020.e19021 en http://www.redalyc.org/revista.oa?id=2736 Mercator - Revista de Geografia da UFC application/pdf Universidade Federal do Ceará Mercator - Revista de Geografia da UFC (Brasil) Num.3 Vol.19
format Artículo científico
id redalyc_273664287004
institution Redalyc
language en
publishDate 2020
publisher Universidade Federal do Ceará
spellingShingle INTELLECTUAL PROPERTY PROTECTION AND DRUG PATENTS IN BRAZIL
Fabio Tozi
Ciencias de la Tierra
19
COVID
Patents
Medicines
Intellectual Property (IP)
INTELLECTUAL PROPERTY PROTECTION AND DRUG PATENTS IN BRAZIL Fabio Tozi Ciencias de la Tierra 19 COVID Patents Medicines Intellectual Property (IP) The article aims to reconstitute the central events of the Intellectual Property (IP) protection system in Brazil, highlighting the exception of medicines patent granting. In a second moment, we discuss the influences of corporations and of Special 301 Reports in the Intellectual Property Law (1996), which marks the recognition of drug patents granting in the country. Subsequently, we present an analysis of the growth of patents inthe largest offices, highlighting Brazil's peripheral participation in innovation. Finally, the article seeks to demonstrate the current relationship between patents and public health by considering the patent invalidation in Brazil and the international cooperation between States and corporations in developing vaccines during the COVID-19 pandemic. 2020 artículo científico 1984-2201 https://www.redalyc.org/articulo.oa?id=273664287004 https://www.redalyc.org/journal/2736/273664287004/ https://www.redalyc.org/journal/2736/273664287004/html/ https://www.redalyc.org/journal/2736/273664287004/273664287004.epub https://www.redalyc.org/journal/2736/273664287004/movil https://doi.org/10.4215/rm2020.e19021 en http://www.redalyc.org/revista.oa?id=2736 Mercator - Revista de Geografia da UFC application/pdf Universidade Federal do Ceará Mercator - Revista de Geografia da UFC (Brasil) Num.3 Vol.19
title INTELLECTUAL PROPERTY PROTECTION AND DRUG PATENTS IN BRAZIL
topic Ciencias de la Tierra
19
COVID
Patents
Medicines
Intellectual Property (IP)
url https://www.redalyc.org/articulo.oa?id=273664287004
https://www.redalyc.org/journal/2736/273664287004/
https://www.redalyc.org/journal/2736/273664287004/html/
https://www.redalyc.org/journal/2736/273664287004/273664287004.epub
https://www.redalyc.org/journal/2736/273664287004/movil
https://doi.org/10.4215/rm2020.e19021